개인구독
소속 기관이 없으신 경우, 개인 정기구독을 하시면 저렴하게
논문을 무제한 열람 이용할 수 있어요.
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2021.5
- 수록면
- 1 - 14 (14page)
- DOI
- 10.1038/s12276-021-00614-x
이용수
초록· 키워드
오류제보하기
Imbalance between fat production and consumption causes various metabolic disorders. Nonalcoholic fatty liver disease (NAFLD), one such pathology, is characterized by abnormally increased fat synthesis and subsequent fat accumulation in hepatocytes 1,2 . While often comorbid with obesity and insulin resistance, this disease can also be found in lean individuals, suggesting specific metabolic dysfunction 2 . NAFLD has become one of the most prevalent liver diseases in adults worldwide, but its incidence in both children and adolescents has also markedly increased in developed nations 3,4 . Progression of this disease into nonalcoholic steatohepatitis (NASH), cirrhosis, liver failure, and hepatocellular carcinoma in combination with its widespread incidence thus makes NAFLD and its related pathologies a significant public health concern. Here, we review our understanding of the roles of dietary carbohydrates (glucose, fructose, and fibers) and the gut microbiota, which provides essential carbon sources for hepatic fat synthesis during the development of NAFLD.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Roles of IκB kinases and TANK-binding kinase 1 in hepatic lipid metabolism and nonalcoholic fatty liver disease
Experimental and Molecular Medicine
2021 .11
-
Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma
Experimental and Molecular Medicine
2020 .08
-
Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes
Experimental and Molecular Medicine
2017 .01
-
The impact of endotrophin on the progression of chronic liver disease
Experimental and Molecular Medicine
2020 .10
-
Immature Citrus unshiu extract decreases fatty liver in rat with non-alcoholic fatty liver disease
한국생물공학회 학술대회
2016 .10
-
The gut microbiota: a key regulator of metabolic diseases
BMB Reports
2016 .01
-
Porphyromonas gingivalis exacerbates the progression of fatty liver disease via CD36-PPARγ pathway
BMB Reports
2021 .01
-
Vitamin D ameliorates age-induced nonalcoholic fatty liver disease by increasing the mitochondrial contact site and cristae organizing system (MICOS) 60 level
Experimental and Molecular Medicine
2024 .01
-
Insulin receptor substrate 2: a bridge between Hippo and AKT pathways
BMB Reports
2018 .01
-
Current Understanding of Stem Cell and Secretome Therapies in Liver Diseases
조직공학과 재생의학
2017 .01
-
Dnmt1/Tet2-mediated changes in Cmip methylation regulate the development of nonalcoholic fatty liver disease by controlling the Gbp2-Pparγ-CD36 axis
Experimental and Molecular Medicine
2023 .01
-
A Fuzzy Decision Support System for Diagnosis of Some Liver Diseases in Educational Medical Institutions
INTERNATIONAL JOURNAL of FUZZY LOGIC and INTELLIGENT SYSTEMS
2020 .12
-
Segmentation and Rigid Registration of Liver Dynamic Computed Tomography Images for Diagnostic Assessment of Fatty Liver Disease
Journal of Computing Science and Engineering
2023 .09
-
From genome sequencing to the discovery of potential biomarkers in liver disease
BMB Reports
2020 .01
-
성인 남성에서 진단된 지방간 정도와 혈액학적 검사 및비만지표의 상관관계
방사선산업학회지
2021 .01
-
GPx7 ameliorates non-alcoholic steatohepatitis by regulating oxidative stress
BMB Reports
2020 .01
-
Gut Microbial Metabolite: Promising Therapeutics for Liver Disease
한국생물공학회 학술대회
2022 .09
-
한국 성인의 대사 위험인자 패턴 및 영양상태와 심뇌혈관질환 또는 지방간 발생 위험률: 전향적 코호트 연구
보건정보통계학회지
2023 .05
-
The interplay of microRNAs and transcription factors in autophagy regulation in nonalcoholic fatty liver disease
Experimental and Molecular Medicine
2021 .04
-
Poly-(γ-D-Glutamic Acid) Ameliorates Metabolic Dysfunction by Modulating Metabolic Gene Expression and Attenuating Intestinal Barrier Injury
한국생물공학회 학술대회
2022 .09
이 논문의 저자 정보
최근 본 자료
댓글(0)
0